Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Northern Trust Corporation Common Stock (NTRS) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Northern Trust Corporation Common StockTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Northern Trust Corporation Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Northern Trust Corporation Common Stock trades at $162.48 (market cap $30.63B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Northern Trust Corporation Common Stock is far larger — about 20.7× uniQure N.V. Ordinary Shares's market cap, and Northern Trust Corporation Common Stock pays a 1.96% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Northern Trust Corporation Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

NTRSQURE
Market Cap
$30.63B$1.48B
Volume
964,5502,488,780
Sector
FinancialsHealth
52-Week High
$191.47$70.59
52-Week Low
$122.72$9.03
Typical Hold Time
0 Days0 Days
Enterprise Value
-$5.35B$728.62M
Dividend Yield
1.96%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NTRS
100% Buy0% Sell
Avg holding period · 0 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Northern Trust Corporation Common Stock

Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.

Read more on NTRS →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →